Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fresenius Medical Care AG (FMS) Shares Outstanding (Diluted Average) (2016 - 2023)

Historic Shares Outstanding (Diluted Average) for Fresenius Medical Care AG (FMS) over the last 10 years, with Q2 2023 value amounting to $838471.7.

  • Fresenius Medical Care AG's Shares Outstanding (Diluted Average) changed N/A to $838471.7 in Q2 2023 from the same period last year, while for Jun 2023 it was $838471.7, marking a year-over-year change of. This contributed to the annual value of $7.6 million for FY2018, which is N/A changed from last year.
  • Latest data reveals that Fresenius Medical Care AG reported Shares Outstanding (Diluted Average) of $838471.7 as of Q2 2023.
  • Fresenius Medical Care AG's 5-year Shares Outstanding (Diluted Average) high stood at $2.4 million for Q2 2020, and its period low was $838471.7 during Q2 2023.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $1.4 million, with a median of $1.0 million in 2020.
  • The largest annual percentage gain for Fresenius Medical Care AG's Shares Outstanding (Diluted Average) in the last 5 years was 223.52% (2021), contrasted with its biggest fall of 1825.49% (2021).
  • Quarter analysis of 3 years shows Fresenius Medical Care AG's Shares Outstanding (Diluted Average) stood at $2.4 million in 2020, then fell by 18.25% to $1.9 million in 2021, then tumbled by 56.48% to $838471.7 in 2023.
  • Its last three reported values are $838471.7 in Q2 2023, $1.9 million for Q2 2021, and $1.0 million during Q1 2021.